Non-genetic Causes of Th17/Treg Imbalance and its Impact on Systematic Autoimmune Diseases
DOI:
https://doi.org/10.61173/pp9kh460Keywords:
Treg imbalance, Autoimmune diseases, Immune system regulationAbstract
Autoimmune is the situation that immune system loses self-tolerance and attacks tissues, causing inflammatory responses. Th17/Treg imbalance is the case that quantity or efficacy of pro-inflammatory helper T cell Th17 is greater than suppressive regulatory T cell, which widely observed in autoimmune diseases. Research on Th17/Treg imbalance initialized from discovering similarity between Th17 and Treg development and activation of their critical transcriptional regulator RORγt and Foxp3. In decades of studies, researchers have successfully identified risk factors and possible reasons inducing Th17/Treg imbalance, including infection, diet, environment and gut microbiota etc. Moreover, several trials of treatment based on knowledge of Th17/Treg imbalance have been successful. However, though several explanations leading to imbalance have risen, detailed signalling pathways and protein mechanisms have remained unknown due to complexity of experimental proof. This review summarizes current researching progress on understanding how Th17 and Treg matures and compares their similarity in differentiation. Moreover, this review explains the role of Th17 and Treg in immune system, and analyzes the detrimental result and reasons for Th17/Treg imbalance, using some systematic autoimmune diseases as examples. Research in Th17/Treg explains why systematic autoimmune diseases and other types of hypersensitivity can prolong excluding genetic deficiency, and discovers optimal targets to ameliorate symptoms. Future studies should explain in detail mechanism which external factors can cause imbalance and why imbalance still generates albeit sufficient conditions for Treg differentiation possess.
References
[1] Li R, Li H, Yang X, Hu H, Liu P, Liu H. Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis. Front Immunol. 2022 Sep 13;13:970508.
[2] Yu X, Harden K, Gonzalez LC, Francesco M, Chiang E, Irving B, Tom I, Ivelja S, Refino CJ, Clark H, Eaton D, Grogan JL. The surface protein TIGIT suppresses T cell activation by promoting the generation of mature immunoregulatory dendritic cells. Nat Immunol. 2009 Jan;10(1):48-57.
[3] Ouyang W, Beckett O, Ma Q, Paik JH, DePinho RA, Li MO. Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol. 2010 Jul;11(7):618-27.
[4] Wang K, Fu W. Transcriptional regulation of Treg homeostasis and functional specification. Cell Mol Life Sci. 2020 Nov;77(21):4269-4287.
[5] Bianchi E, Rogge L. The IL-23/IL-17 pathway in human chronic inflammatory diseases—new insight from genetics and targeted therapies. Genes Immun. 2019;20:415–425.
[6] Ma R, Su H, Jiao K, Liu J. Role of Th17 cells, Treg cells, and Th17/Treg imbalance in immune homeostasis disorders in patients with chronic obstructive pulmonary disease. Immun Inflamm Dis. 2023 Feb;11(2):e784.
[7] Chen L, Wu J, Pier E, Zhao Y, Shen Z. mTORC2-PKBalpha/ Akt1 Serine 473 phosphorylation axis is essential for regulation of FOXP3 Stability by chemokine CCL3 in psoriasis. J Invest Dermatol. 2013;133:418–28.
[8] Song X, Li B, Xiao Y, Chen C, Wang Q, Liu Y, et al. Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function. Cell Rep. 2017;1:665–75.
[9] Liu B, Salgado OC, Singh S, et al. The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation. Nat Commun. 2019;10:354.
[10] Jorg van Loosdregt, Yvonne Vercoulen, Teun Guichelaar, et al. Coffer, Regulation of Treg functionality by acetylationmediated Foxp3 protein stabilization, Blood. 2010;115:965-974.
[11] Pompura SL, Dominguez-Villar M. The PI3K/AKT signaling pathway in regulatory T-cell development, stability, and function. J Leukoc Biol. 2018 Jan 22.
[12] Zhu H, Liu Z, An J, et al. Activation of AMPKα1 is essential for regulatory T cell function and autoimmune liver disease prevention. Cell Mol Immunol. 2021;18:2609–2617.
[13] Zhang S, Zhong R, Tang S, Chen L, Zhang H. Metabolic regulation of the Th17/Treg balance in inflammatory bowel disease. Pharmacological Research. 2024;203:107184.
[14] Cheng H, Guan X, Chen D, Ma W. The Th17/Treg Cell Balance: A Gut Microbiota-Modulated Story. Microorganisms. 2019 Nov 20;7(12):583.
[15] Mann ER, Lam YK, Uhlig HH. Short-chain fatty acids: linking diet, the microbiome and immunity. Nat Rev Immunol. 2024.
[16] Jiang Q, Yang G, Liu Q, Wang S, Cui D. Function and Role of Regulatory T Cells in Rheumatoid Arthritis. Front Immunol. 2021 Apr 1;12:626193.
[17] Ohl K, Tenbrock K. Regulatory T cells in systemic lupus erythematosus. Eur J Immunol. 2015 Feb;45(2):344-55.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 by the authors.
This work is licensed under a Creative Commons Attribution 4.0 International License.
